Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Airway hyperresponsiveness and mucus secretion].

S Shimura1, T Sasaki, H Ishihara

  • 1First Department of Internal Medicine, Tohoku University School of Medicine, Sensai, Japan.

Nihon Kyobu Shikkan Gakkai Zasshi
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alternative promoters regulate transcription of the mouse GATA-2 gene.

The Journal of biological chemistry·1998
Same author

[New PI kinase family and vesicular transport].

Nihon rinsho. Japanese journal of clinical medicine·1998
Same author

ONO-5046, an elastase inhibitor, attenuates liver mitochondrial dysfunction after endotoxin.

Critical care medicine·1998
Same author

Pituitary adenylate cyclase-activating polypeptide (PACAP) is an islet substance serving as an intra-islet amplifier of glucose-induced insulin secretion in rats.

The Journal of physiology·1998
Same author

Detection and cloning of unique integration sites of retrotransposon, intracisternal A-particle element in the genome of acute myeloid leukemia cells in mice.

FEBS letters·1997
Same author

A regional variation of acetylcholine-induced relaxation in different segments of rat aorta.

Physiology & behavior·1997
Same journal

[A case of expanding pulmonary aspergilloma].

Nihon Kyobu Shikkan Gakkai zasshi·1998
Same journal

[A resected case of intralobar pulmonary sequestration with increased serum tumor markers, CA19-9, CA125 and NCC-ST-439].

Nihon Kyobu Shikkan Gakkai zasshi·1998
Same journal

[A case of allergic bronchopulmonary aspergillosis caused by Aspergillus terreus].

Nihon Kyobu Shikkan Gakkai zasshi·1998
Same journal

[Pulmonary thromboembolism associated with antiphospholipid syndrome in scleroderma].

Nihon Kyobu Shikkan Gakkai zasshi·1998
Same journal

[Clinical investigation of three cases of pulmonary eosinophilic granuloma].

Nihon Kyobu Shikkan Gakkai zasshi·1998
Same journal

[A case of primary acute pulmonary cavitation in sarcoidosis complicated by multiple nodular lesions in the central nervous system].

Nihon Kyobu Shikkan Gakkai zasshi·1998
See all related articles

Asthma mucus hypersecretion may stem from reduced inhibitory factors. Damaged airway epithelial cells in asthmatics might impair mucus regulation, leading to airway obstruction.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Immunology

Background:

  • Bronchial asthma is characterized by excessive mucus and mucoid impaction in the lungs.
  • This mucus accumulation can lead to bronchial obstruction and hyperresponsiveness.
  • Bronchial glands are central to airway mucus secretion.

Purpose of the Study:

  • To investigate the mechanisms regulating airway mucus secretion.
  • To examine the role of chemical mediators and epithelial cells in mucus hypersecretion.
  • To understand the contribution of bronchial gland secretion in asthma.

Main Methods:

  • Utilized isolated bronchial gland preparations for controlled mucus secretion studies.
  • Investigated the effects of mast cell mediators, platelet-activating factor (PAF), and Substance P.

Related Experiment Videos

  • Examined the role of epithelial cell-derived factors in regulating mucus secretion.

    • Main Results:

    • Cholinergic nerve stimulation augmented secretory responses via acetylcholine release.
    • Platelet-activating factor (PAF) increased mucus glycoprotein secretion, mediated by thromboxane release.
    • Substance P also stimulated mucus secretion.
    • Epithelial cells release an inhibitory factor for mucus secretion.

    Conclusions:

    • Airway inflammation and epithelial cell damage in asthma may reduce inhibitory factor release.
    • This reduction in inhibition could lead to mucus hypersecretion in bronchial asthmatics.
    • Understanding these mechanisms is crucial for managing asthma-related mucus production.